MSFT 437.49 1.4587% AAPL 242.99 0.1401% NVDA 145.11 3.4579% GOOGL 174.36 1.7626% GOOG 176.05 1.7512% AMZN 218.21 2.2348% META 613.54 -0.0179% AVGO 170.365 1.3173% TSLA 357.75 1.8013% TSM 200.69 0.905% LLY 833.585 2.4904% V 310.57 -0.7795% JPM 243.555 -0.5167% UNH 610.73 0.9087% NVO 109.26 0.0549% WMT 94.295 0.8395% LVMUY 127.2 -0.9269% XOM 114.29 -2.8724% LVMHF 638.8 -0.6084% MA 521.685 -0.8543%
Last update at 2024-12-04T20:52:00Z
AbbVie is buying an Alzheimer's drug for more than $1 billion
Mon 28 Oct 24, 03:16 PMAbbVie (ABBV): Growth Driven by Skyrizi, Rinvoq, and Strategic Acquisitions
Fri 18 Oct 24, 07:25 PMPharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New Drugs
Fri 18 Oct 24, 07:00 PMAbbVie Secures FDA Approval for Parkinson's Disease Drug Vyalev
Fri 18 Oct 24, 01:04 PM3 Growth Stocks That Could Be Bargain Buys Right Now
Fri 18 Oct 24, 09:20 AMJim Cramer Says AbbVie Inc. (ABBV) ‘Is Doing Very, Very Well’
Fri 18 Oct 24, 01:16 AMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 13477.00M | 12989.00M | 3398.00M | 8426.00M | 5197.00M |
Minority interest | -9.00000M | -7.00000M | 6.00M | 21.00M | 21.00M |
Net income | 11836.00M | 11542.00M | 4616.00M | 7882.00M | 5687.00M |
Selling general administrative | 15260.00M | 12349.00M | 11299.00M | 6942.00M | 7399.00M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 40640.00M | 38751.00M | 30417.00M | 25827.00M | 25035.00M |
Reconciled depreciation | 8467.00M | 8521.00M | 6471.00M | 2017.00M | 1765.00M |
Ebit | 18117.00M | 17924.00M | 476.00M | 12983.00M | 6383.00M |
Ebitda | 26584.00M | 26445.00M | 6947.00M | 13795.00M | 8148.00M |
Depreciation and amortization | 8467.00M | 8521.00M | 6471.00M | 812.00M | 1765.00M |
Non operating income net other | -2596.00000M | -2551.00000M | -5685.00000M | -3048.00000M | -42.00000M |
Operating income | 18117.00M | 17924.00M | 476.00M | 12983.00M | 6383.00M |
Other operating expenses | 39240.00M | 37311.00M | 33243.00M | 19898.00M | 25946.00M |
Interest expense | 2230.00M | 2384.00M | 2280.00M | 1509.00M | 1144.00M |
Tax provision | 1632.00M | 1440.00M | -1224.00000M | 544.00M | -490.00000M |
Interest income | 186.00M | 39.00M | 174.00M | 275.00M | 204.00M |
Net interest income | -2044.00000M | -2384.00000M | -2280.00000M | -1509.00000M | -1144.00000M |
Extraordinary items | - | - | - | - | -86.00000M |
Non recurring | 697.00M | 962.00M | 1198.00M | 385.00M | 424.00M |
Other items | - | - | - | - | - |
Income tax expense | 1632.00M | 1440.00M | -1224.00000M | 544.00M | -490.00000M |
Total revenue | 58054.00M | 56197.00M | 45804.00M | 33266.00M | 32753.00M |
Total operating expenses | 21826.00M | 19865.00M | 17856.00M | 12459.00M | 18228.00M |
Cost of revenue | 17414.00M | 17446.00M | 15387.00M | 7439.00M | 7718.00M |
Total other income expense net | -3293.00000M | -3513.00000M | 2922.00M | -4557.00000M | -466.00000M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 11845.00M | 11549.00M | 4622.00M | 7882.00M | 5687.00M |
Net income applicable to common shares | 11836.00M | 11542.00M | 4616.00M | 7882.00M | 5687.00M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 138805.00M | 146529.00M | 150565.00M | 89115.00M | 59352.00M |
Intangible assets | 67439.00M | 75951.00M | 82876.00M | 18649.00M | 21233.00M |
Earning assets | - | - | - | - | - |
Other current assets | 4401.00M | 4993.00M | 3562.00M | 2354.00M | 1895.00M |
Total liab | 121518.00M | 131093.00M | 137468.00M | 97287.00M | 67798.00M |
Total stockholder equity | 17254.00M | 15408.00M | 13076.00M | -8172.00000M | -8446.00000M |